These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12928923)

  • 21. The cellular inflammatory response in human spinal cords after injury.
    Fleming JC; Norenberg MD; Ramsay DA; Dekaban GA; Marcillo AE; Saenz AD; Pasquale-Styles M; Dietrich WD; Weaver LC
    Brain; 2006 Dec; 129(Pt 12):3249-69. PubMed ID: 17071951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic Myelomonocytic Leukemia Mimicking Invasive Fungal Rhinosinusitis.
    Climans SA; Cecchini MJ; Hsia CC; Bondy LC; Shkrum MJ; Roth KE; Fraser JA
    Can J Neurol Sci; 2018 Sep; 45(5):596-598. PubMed ID: 30234474
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pleural involvement in the course of chronic myelomonocytic leukemia and the development of multiple colonic perforation due to leukemic infiltration in the acute leukemia phase].
    Watanabe N; Takahashi T; Sakamoto Y; Tanaka Y; Kurata M; Matsushita A; Maeda A; Nagai K; Shirane H
    Rinsho Ketsueki; 2004 Jul; 45(7):546-50. PubMed ID: 15359914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary haemophagocytic lymphohistiocytosis (SHLH) occurring in chronic myelomonocytic leukaemia.
    Marmont A; Gualandi F
    Br J Haematol; 2004 Oct; 127(1):2. PubMed ID: 15384971
    [No Abstract]   [Full Text] [Related]  

  • 25. Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study.
    Jestin M; Tarfi S; Duchmann M; Badaoui B; Freynet N; Tran Quang V; Sloma I; Droin N; Morabito M; Leclerc M; Maury S; Fenaux P; Solary E; Selimoglu-Buet D; Wagner-Ballon O;
    Leukemia; 2021 Mar; 35(3):893-896. PubMed ID: 32684630
    [No Abstract]   [Full Text] [Related]  

  • 26. Chronic myelomonocytic leukemia.
    Maslak P; McKenzie S
    Blood; 2003 Dec; 102(12):3863. PubMed ID: 14666928
    [No Abstract]   [Full Text] [Related]  

  • 27. Analysis of factors associated with short-term survival in chronic myelomonocytic leukemia.
    Molica S; Iannaccaro P
    Haematologica; 1990; 75(2):195-6. PubMed ID: 2358210
    [No Abstract]   [Full Text] [Related]  

  • 28. Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging.
    Gilmore CP; Geurts JJ; Evangelou N; Bot JC; van Schijndel RA; Pouwels PJ; Barkhof F; Bö L
    Mult Scler; 2009 Feb; 15(2):180-8. PubMed ID: 18845658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly selective leptomeningeal amyloidosis with transthyretin variant Ala25Thr.
    Hagiwara K; Ochi H; Suzuki S; Shimizu Y; Tokuda T; Murai H; Shigeto H; Ohyagi Y; Iwata M; Iwaki T; Kira JI
    Neurology; 2009 Apr; 72(15):1358-60. PubMed ID: 19365058
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
    Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
    Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
    Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
    Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chronic myelomonocytic leukemia].
    Furusawa S; Tadokoro J
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):201-5. PubMed ID: 9851121
    [No Abstract]   [Full Text] [Related]  

  • 33. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
    Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
    Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laryngeal infiltration in chronic myelomonocytic leukaemia.
    Brito-Babapulle F; Barbatis C; Whitmore DN
    Clin Lab Haematol; 1989; 11(4):403-6. PubMed ID: 2605881
    [No Abstract]   [Full Text] [Related]  

  • 35. Chronic myelomonocytic leukemia with p190 BCR-ABL rearrangement mimicking advanced liver disease at presentation.
    Alagiozian-Angelova V; Kadkol S; Lindgren V; Peace D; Gaitonde S
    Acta Oncol; 2007; 46(4):554-6. PubMed ID: 17497325
    [No Abstract]   [Full Text] [Related]  

  • 36. Pyoderma gangrenosum as initial presentation of chronic myelomonocytic leukemia.
    Sung CC; Chang PY; Wu YY; Hsu YC; Chiang CP; Chen YC
    Eur J Haematol; 2009 May; 82(5):410. PubMed ID: 19187272
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of monocyte subset repartitioning by flow cytometry for diagnosis of chronic myelomonocytic leukaemia.
    Murali A; Cross D; Mollee P
    Blood Cancer J; 2021 Jan; 11(1):6. PubMed ID: 33414421
    [No Abstract]   [Full Text] [Related]  

  • 38. Recombinant human interleukin-10 in patients with chronic myelomonocytic leukemia.
    Pöchlauer S; Jäger E; Jäger U; Geissler K
    Ann Hematol; 2014 Oct; 93(10):1775-6. PubMed ID: 24441916
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis.
    Nakamura M; Yamashita T; Ueda M; Obayashi K; Sato T; Ikeda T; Washimi Y; Hirai T; Kuwahara Y; Yamamoto MT; Uchino M; Ando Y
    Neurology; 2005 Oct; 65(7):1051-6. PubMed ID: 16217058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic myelomonocytic leukemia with pleural effusion as the first clinical sign].
    Yamazaki E; Kanai M; Sakai R; Sakamoto H; Ishigatsubo Y
    Rinsho Ketsueki; 2005 Mar; 46(3):217-9. PubMed ID: 16447718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.